{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:00:17Z","timestamp":1791115217945,"version":"4.1.0"},"reference-count":113,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":944,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/bjd.12104","type":"journal-article","created":{"date-parts":[[2012,10,27]],"date-time":"2012-10-27T03:33:43Z","timestamp":1351308823000},"page":"243-252","source":"Crossref","is-referenced-by-count":94,"title":["Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review"],"prefix":"10.1093","volume":"168","author":[{"given":"J.L.","family":"Blok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"van Hattem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Jonkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,1,30]]},"reference":[{"key":"10.1111\/bjd.12104-BIB1|cit1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB2|cit2","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-33101-8","volume-title":"Hidradenitis Suppurativa","author":"Jemec","year":"2006"},{"key":"10.1111\/bjd.12104-BIB3|cit3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2009.09.021","article-title":"Hidradenitis suppurativa markedly decreases quality of life and professional activity","volume":"62","author":"Matusiak","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB4|cit4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB5|cit5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.12104-BIB6|cit6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archdermatol.2011.1950","article-title":"A systematic review of treatments for hidradenitis suppurativa","volume":"148","author":"Rambhatla","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12104-BIB7|cit7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2340\/00015555-0747","article-title":"Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors","volume":"89","author":"Haslund","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12104-BIB8|cit8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2133.1995.tb02624.x","article-title":"The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands","volume":"133","author":"Attanoos","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB9|cit9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","article-title":"Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae","volume":"164","author":"von Laffert","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB10|cit10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0190-9622(96)90277-7","article-title":"Histology of hidradenitis suppurativa","volume":"34","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB11|cit11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-4632.2004.02536.x","article-title":"\u2018Hidradenitis suppurativa\u2019 is acne inversa! An appeal to (finally) abandon a misnomer","volume":"44","author":"Sellheyer","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12104-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.08.047","article-title":"Pathogenesis and pharmacotherapy of hidradenitis suppurativa","volume":"672","author":"Nazary","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/bjd.12104-BIB13|cit13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB14|cit14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents?","volume":"89","author":"Matusiak","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12104-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa","volume":"186","author":"Wolk","year":"2011","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12104-BIB17|cit17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archdermatol.2007.28","article-title":"Systematic reviews: grading recommendations and evidence quality","volume":"144","author":"Robinson","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12104-BIB18|cit18","first-page":"644","article-title":"Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa","volume":"20","author":"Brunasso","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.12104-BIB19|cit19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/09546634.2011.571657","article-title":"Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa","volume":"23","author":"van Rappard","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.12104-BIB20|cit20","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1365-4632.2010.04545.x","article-title":"A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa","volume":"49","author":"Amano","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12104-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1365-4632.2010.04638.x","article-title":"Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy","volume":"49","author":"Arenbergerova","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12104-BIB22|cit22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1610-0387.2008.06918.x","article-title":"Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab","volume":"7","author":"Harde","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.12104-BIB23|cit23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archdermatol.2009.49","article-title":"Long-term successful adalimumab therapy in severe hidradenitis suppurativa","volume":"145","author":"Blanco","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12104-BIB24|cit24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000251217","article-title":"Successful treatment of recalcitrant hidradenitis suppurativa with adalimumab","volume":"1","author":"Gorovoy","year":"2009","journal-title":"Case Rep Dermatol"},{"key":"10.1111\/bjd.12104-BIB25|cit25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1684\/ejd.2008.0599","article-title":"Efficacy of adalimumab in recalcitrant hidradenitis suppurativa","volume":"19","author":"Sotiriou","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.12104-BIB26|cit26","first-page":"181","article-title":"Hidradenitis suppurativa managed with adalimumab","volume":"8","author":"Yamauchi","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.12104-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archderm.142.9.1110","article-title":"The cutting edge. Severe hidradenitis suppurativa treated with adalimumab","volume":"142","author":"Moul","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12104-BIB28|cit28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jaad.2006.01.024","article-title":"Treatment of coincident seronegative arthritis and hidradenitis suppurativa with adalimumab","volume":"55","author":"Scheinfeld","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/ICO.0b013e3181d4fd5c","article-title":"Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review","volume":"29","author":"Alzaga Fernandez","year":"2010","journal-title":"Cornea"},{"key":"10.1111\/bjd.12104-BIB30|cit30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ajg.2009.489","article-title":"A case of hidradenitis suppurativa refractory to anti-TNF\u03b1 therapy in a patient with Crohn\u2019s disease","volume":"105","author":"Koilakou","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/bjd.12104-BIB31|cit31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB32|cit32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2133.2011.10698.x","article-title":"Adalimumab (antitumour necrosis factor-\u03b1) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study","volume":"166","author":"van der Zee","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB33|cit33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archdermatol.2010.72","article-title":"Treatment of hidradenitis suppurativa with etanercept injection","volume":"146","author":"Adams","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12104-BIB34|cit34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaad.2008.11.898","article-title":"A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa","volume":"60","author":"Lee","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB35|cit35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2007.08372.x","article-title":"An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa","volume":"158","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1468-3083.2008.02617.x","article-title":"Long-term efficacy of etanercept in hidradenitis suppurativa","volume":"22","author":"Zangrilli","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12104-BIB37|cit37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","article-title":"Etanercept: effective in the management of hidradenitis suppurativa","volume":"154","author":"Cusack","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB38|cit38","first-page":"1010","article-title":"Case reports: treatment of atypical hidradenitis suppurativa with the tumor necrosis factor receptor-Fc fusion protein etanercept","volume":"5","author":"Henderson","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.12104-BIB39|cit39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2340\/00015555-0545","article-title":"Etanercept for the treatment of hidradenitis suppurativa","volume":"89","author":"Sotiriou","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12104-BIB40|cit40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.farma.2010.10.003","article-title":"Partial response to etanercept in the treatment of hidradenitis suppurativa","volume":"35","author":"Lopez-Martin","year":"2011","journal-title":"Farm Hosp"},{"key":"10.1111\/bjd.12104-BIB41|cit41","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1600-0625.2009.00967.x","article-title":"Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial","volume":"19","author":"Pelekanou","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12104-BIB42|cit42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB43|cit43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2133.2012.10807.x","article-title":"Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions","volume":"167","author":"van Rappard","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB44|cit44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2340\/00015555-1025","article-title":"Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers","volume":"91","author":"Delage","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12104-BIB45|cit45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2133.2008.08735.x","article-title":"Hidradenitis suppurativa: are tumour necrosis factor-\u03b1 blockers the ultimate alternative?","volume":"159","author":"Brunasso","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB46|cit46","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.2007.08332.x","article-title":"Long-term efficacy of a single course of infliximab in hidradenitis suppurativa","volume":"158","author":"Mekkes","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB47|cit47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000102032","article-title":"Infliximab for the treatment of hidradenitis suppurativa","volume":"215","author":"Fernandez-Vozmediano","year":"2007","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12104-BIB48|cit48","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2230.2006.02272.x","article-title":"Variable response of hidradenitis suppurativa to infliximab in four patients","volume":"32","author":"Usmani","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12104-BIB49|cit49","first-page":"185","article-title":"SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate","volume":"69","author":"de Souza","year":"2011","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1111\/bjd.12104-BIB50|cit50","doi-asserted-by":"crossref","first-page":"E801","DOI":"10.1002\/ibd.21897","article-title":"Association and management of Crohn\u2019s disease plus hidradenitis suppurativa","volume":"18","author":"Dos Santos","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/bjd.12104-BIB51|cit51","first-page":"507","article-title":"Acne inversa successfully treated with infliximab","volume":"58","author":"von Preussen","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12104-BIB52|cit52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/apc.2011.0158","article-title":"Severe hidradenitis suppurative in an HIV-positive male: use of multiple treatment modalities, including tumor necrosis factor blockade","volume":"25","author":"Husein-ElAhmed","year":"2011","journal-title":"AIDS Patient Care STDS"},{"key":"10.1111\/bjd.12104-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archdermatol.2010.372","article-title":"Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab","volume":"146","author":"Alecsandru","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12104-BIB54|cit54","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1440-0960.2010.00623.x","article-title":"Hidradenitis suppurativa responding to treatment with infliximab","volume":"51","author":"Lasocki","year":"2010","journal-title":"Australas J Dermatol"},{"key":"10.1111\/bjd.12104-BIB55|cit55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2310\/7750.2008.08034","article-title":"Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept","volume":"13","author":"Poulin","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/bjd.12104-BIB56|cit56","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2340\/00015555-0397","article-title":"Acne inversa treated with infliximab: different outcomes in 2 patients","volume":"88","author":"Antonucci","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12104-BIB57|cit57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.crohns.2008.02.002","article-title":"Efficacy of Infliximab treatment in patients with severe Fistulizing Hidradenitis Suppurativa","volume":"2","author":"Elkjaer","year":"2008","journal-title":"J Crohns Colitis"},{"key":"10.1111\/bjd.12104-BIB58|cit58","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.ejim.2007.11.014","article-title":"Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab","volume":"19","author":"Montes-Romero","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1111\/bjd.12104-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1468-3083.2008.02691.x","article-title":"Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy","volume":"22","author":"Pedraz","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12104-BIB60|cit60","first-page":"CS14","article-title":"Experiences with a long-term treatment of a massive gluteal acne inversa with infliximab in Crohn\u2019s disease","volume":"15","author":"Goertz","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1111\/bjd.12104-BIB61|cit61","first-page":"206","article-title":"A Chinese man with chronic recalcitrant hidradenitis suppurativa successfully treated with infliximab","volume":"16","author":"Kwan","year":"2008","journal-title":"Hong Kong J Dermatol Venereol"},{"key":"10.1111\/bjd.12104-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-4632.2007.03293.x","article-title":"Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases","volume":"46","author":"Moschella","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12104-BIB63|cit63","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2006.07.027","article-title":"Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients","volume":"56","author":"Fardet","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2133.2006.07528.x","article-title":"Long-term infliximab for severe hidradenitis suppurativa","volume":"155","author":"Thielen","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB65|cit65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/09546630410024547","article-title":"Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn\u2019s disease","volume":"16","author":"Rosi","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.12104-BIB66|cit66","first-page":"196","article-title":"Treatment of suppurative hidradenitis with surgical deroofing and infliximab","volume":"14","author":"Mekkes","year":"2004","journal-title":"Ned Tijdschr Dermatol Venereol"},{"key":"10.1111\/bjd.12104-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archderm.139.12.1540","article-title":"Severe hidradenitis suppurativa treated with infliximab infusion","volume":"139","author":"Adams","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12104-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1365-2133.2003.05663.x","article-title":"Infliximab for hidradenitis suppurativa","volume":"149","author":"Sullivan","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB69|cit69","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1016\/S0190-9622(03)01132-0","article-title":"Infliximab for the treatment of hidradenitis suppurativa","volume":"49","author":"Lebwohl","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s00535-003-1185-9","article-title":"Hidradenitis suppurativa associated with Crohn\u2019s disease and spondyloarthropathy: response to anti-TNF therapy","volume":"38","author":"Roussomoustakaki","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.1111\/bjd.12104-BIB71|cit71","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.1572-0241.2002.05950.x","article-title":"Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn\u2019s disease patient","volume":"97","author":"Katsanos","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/bjd.12104-BIB72|cit72","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn\u2019s disease: response to treatment with infliximab","volume":"7","author":"Martinez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/bjd.12104-BIB73|cit73","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2133.2011.10328.x","article-title":"New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab","volume":"165","author":"van Rappard","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB74|cit74","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1590\/S0365-05962010000400028","article-title":"Treatment of hidradenitis suppurativa with infliximab","volume":"85","author":"Torres","year":"2010","journal-title":"An Bras Dermatol"},{"key":"10.1111\/bjd.12104-BIB75|cit75","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ad.2010.06.008","article-title":"Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature","volume":"101","author":"Garcia-Rabasco","year":"2010","journal-title":"Actas Dermosifiliogr"},{"key":"10.1111\/bjd.12104-BIB76|cit76","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","article-title":"Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy","volume":"66","author":"Lozeron","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1111\/bjd.12104-BIB77|cit77","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0365-05962009000600022","article-title":"Hidradenitis suppurativa treated with infliximab","volume":"84","author":"Obadia","year":"2009","journal-title":"An Bras Dermatol"},{"key":"10.1111\/bjd.12104-BIB78|cit78","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.annder.2010.06.001","article-title":"Efficacy of infliximab in the treatment of follicular occlusion triad","volume":"137","author":"Deschamps","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/bjd.12104-BIB79|cit79","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0001-7310(07)70076-5","article-title":"Hidradenitis suppurativa. Response to treatment with infliximab","volume":"98","author":"Pedraz","year":"2007","journal-title":"Actas Dermosifiliogr"},{"key":"10.1111\/bjd.12104-BIB80|cit80","first-page":"799","article-title":"Fatal pneumococcal sepsis in a patient with hidradenitis suppurativa treated with infliximab","volume":"131","author":"Benitez-Macias","year":"2008","journal-title":"Med Clin"},{"key":"10.1111\/bjd.12104-BIB81|cit81","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0151-9638(06)77566-4","article-title":"Fatal epidermoid carcinoma in hidradenitis suppurativa following treatment with infliximab","volume":"133","author":"Maalouf","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/bjd.12104-BIB82|cit82","first-page":"406","article-title":"Infliximab for acne inversa (alias hidradenitis suppurativa)?","volume":"15","author":"Suys","year":"2005","journal-title":"Ned Tijdschr Dermatol Venereol"},{"key":"10.1111\/bjd.12104-BIB83|cit83","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1468-3083.2011.04123.x","article-title":"Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa","volume":"26","author":"Gulliver","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12104-BIB84|cit84","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2340\/00015555-1229","article-title":"Management of recalcitrant hidradenitis suppurativa with ustekinumab","volume":"8","author":"Sharon","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12104-BIB85|cit85","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000182261","article-title":"Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients\u2019 outcome assessment","volume":"218","author":"Soria","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12104-BIB86|cit86","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0190-9622(99)70530-X","article-title":"Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa","volume":"40","author":"Boer","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB87|cit87","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0190-9622(84)70199-X","article-title":"Evaluation of isotretinoin treatment of hidradenitis suppurativa","volume":"11","author":"Dicken","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB88|cit88","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2230.1986.tb00512.x","article-title":"Failure of treatment of familial widespread hidradenitis suppurativa with isotretinoin","volume":"11","author":"Norris","year":"1986","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12104-BIB89|cit89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2230.1999.00451.x","article-title":"Severe vulval apocrine acne successfully treated with prednisolone and isotretinoin","volume":"24","author":"Fearfield","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12104-BIB90|cit90","first-page":"252","article-title":"Hidradenitis suppurativa - lack of success with 13-cis-retinoic acid","volume":"107","author":"Jones","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB91|cit91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-9378(88)90766-1","article-title":"Hidradenitis suppurativa of the anogenital region: response to isotretinoin","volume":"158","author":"Brown","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/bjd.12104-BIB92|cit92","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?","volume":"164","author":"Boer","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB93|cit93","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1992.tb00693.x","article-title":"Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate","volume":"126","author":"Chow","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB94|cit94","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0190-9622(88)80251-2","article-title":"Successful treatment of hidradenitis suppurativa with acitretin","volume":"19","author":"Hogan","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12104-BIB95|cit95","first-page":"287","article-title":"Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report","volume":"69","author":"Scheman","year":"2002","journal-title":"Cutis"},{"key":"10.1111\/bjd.12104-BIB96|cit96","first-page":"51","volume-title":"The Retinoids, a Significant Advance in Dermatology","author":"Stewart","year":"1984"},{"key":"10.1111\/bjd.12104-BIB97|cit97","first-page":"28","article-title":"Retinoid therapy in hidradenitis suppurativa - a report of a case","volume":"18","author":"Vahlquist","year":"1990","journal-title":"Retinoids Today Tom"},{"key":"10.1111\/bjd.12104-BIB98|cit98","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: a series of 24 patients","volume":"222","author":"Yazdanyar","year":"2011","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12104-BIB99|cit99","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09546630600830588","article-title":"Hidradenitis suppurativa treated with dapsone: a case series of five patients","volume":"17","author":"Kaur","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.12104-BIB100|cit100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001050170015","article-title":"Acne inversa: a dapsone-sensitive dermatosis","volume":"52","author":"Hofer","year":"2001","journal-title":"Hautarzt"},{"key":"10.1111\/bjd.12104-BIB101|cit101","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000332846","article-title":"The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa","volume":"223","author":"van der Zee","year":"2011","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12104-BIB102|cit102","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2230.2005.01983.x","article-title":"Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin","volume":"31","author":"Rose","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12104-BIB103|cit103","first-page":"289P","article-title":"Cyclosporin-responsive hidradenitis suppurativa","volume":"88","author":"Buckley","year":"1995","journal-title":"J R Soc Med"},{"key":"10.1111\/bjd.12104-BIB104|cit104","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archderm.1990.01670270071012","article-title":"Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12104-BIB105|cit105","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2230.2002.11125.x","article-title":"Methotrexate is of limited value in the treatment of hidradenitis suppurativa","volume":"27","author":"Jemec","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12104-BIB106|cit106","doi-asserted-by":"crossref","DOI":"10.3109\/09546634.2012.674193","article-title":"The off-label treatment of severe hidradenitis suppurativa with TNF-alpha inhibitors: a systematic review","author":"van Rappard","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.12104-BIB107|cit107","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","article-title":"Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae","volume":"164","author":"von Laffert","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12104-BIB108|cit108","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1600-0625.2009.00915.x","article-title":"Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis","volume":"19","author":"Laffert","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12104-BIB109|cit109","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000246125","article-title":"Sebum excretion in hidradenitis suppurativa","volume":"194","author":"Jemec","year":"1997","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12104-BIB110|cit110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clindermatol.2009.03.005","article-title":"The role of isotretinoin in acne therapy: why not as first-line therapy? Facts and controversies","volume":"28","author":"Rigopoulos","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1111\/bjd.12104-BIB111|cit111","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2012.111","article-title":"Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients","volume":"132","author":"Dispenza","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12104-BIB112|cit112","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","volume":"2","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.12104-BIB113|cit113","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0190-9622(99)70359-2","article-title":"Acitretin in psoriasis: an overview of adverse effects","volume":"41","author":"Katz","year":"1999","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12104","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12104\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T08:06:34Z","timestamp":1687766794000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/168\/2\/243\/6614361"}},"subtitle":["Systemic immunosuppressive therapy and retinoids for HS"],"short-title":[],"issued":{"date-parts":[[2013,1,30]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12104","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717962521.793465417","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717962521.793465851","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,30]]}}}